Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Enterprise Value (2023 - 2025)

Historic Enterprise Value for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to -$59.3 million.

  • Rallybio's Enterprise Value rose 2105.43% to -$59.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.3 million, marking a year-over-year increase of 2105.43%. This contributed to the annual value of -$65.5 million for FY2024, which is 4040.61% up from last year.
  • Latest data reveals that Rallybio reported Enterprise Value of -$59.3 million as of Q3 2025, which was up 2105.43% from -$45.7 million recorded in Q2 2025.
  • Rallybio's 5-year Enterprise Value high stood at -$45.7 million for Q2 2025, and its period low was -$150.4 million during Q1 2023.
  • Over the past 3 years, Rallybio's median Enterprise Value value was -$88.6 million (recorded in 2024), while the average stood at -$91.1 million.
  • The largest annual percentage gain for Rallybio's Enterprise Value in the last 5 years was 4837.27% (2025), contrasted with its biggest fall of 2105.43% (2025).
  • Over the past 3 years, Rallybio's Enterprise Value (Quarter) stood at -$109.9 million in 2023, then skyrocketed by 40.41% to -$65.5 million in 2024, then grew by 9.45% to -$59.3 million in 2025.
  • Its last three reported values are -$59.3 million in Q3 2025, -$45.7 million for Q2 2025, and -$54.5 million during Q1 2025.